Newer cardiotonic agents: Implications for patients with heart failure and ischemic heart disease
- 28 February 1987
- journal article
- review article
- Published by Elsevier in Journal of Cardiothoracic Anesthesia
- Vol. 1 (1) , 59-70
- https://doi.org/10.1016/s0888-6296(87)92838-9
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure.Circulation, 1985
- Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.Circulation, 1985
- Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.Circulation, 1985
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary bypass in man.Circulation, 1978
- Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs.Circulation, 1976
- Arterial Sodium Content in Experimental Congestive Heart FailureCirculation, 1970